GKB Ophthalmics Complete Financial Statements
In FY2026, GKB Ophthalmics (GKB) reported revenue ₹31 Cr, net profit ₹1 Cr and EPS ₹0.38, with a net profit margin of 3.2% and ROE of 1.9%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review GKB P/E comparison to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
GKB Revenue, Net Profit & EBITDA — Year-on-Year Growth
GKB YoY (Mar 2025 vs Mar 2026), net profit +125.0%, EBITDA +166.7%, expenses -17.6%. For live price, earnings ratios and company overview, see GKB screener.
GKB Income Statement — Revenue, EBITDA & Net Profit
GKB Ophthalmics revenue ₹31 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹0.38 (2026) — net profit margin 3.2%. Explore GKB investment value to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 31 | 31 | 33 | 58 | 26 | 22 | 26 | 26 | 21 | 20 | 23 | 24 | 19 | 18 | 18 | 19 | 19 | 19 | 16 | 20 | 16 | 16 | 7 | 17 | 14 | 17 | 13 | 16 | 15 | 16 | 12 |
| Expenses | 28 | 27 | 34 | 32 | 55 | 26 | 22 | 25 | 27 | 21 | 20 | 21 | 25 | 17 | 16 | 15 | 19 | 18 | 17 | 14 | 18 | 15 | 15 | 8 | 16 | 14 | 15 | 13 | 15 | 14 | 15 | 13 |
| EBITDA | 2 | 3 | -3 | 1 | 2 | 0 | 1 | 1 | -1 | 0 | 0 | 2 | 0 | 2 | 2 | 3 | 0 | 1 | 2 | 1 | 2 | 1 | 1 | -1 | 2 | 0 | 3 | 1 | 1 | 1 | 1 | -1 |
| Operating Profit Margin % | 5.00% | 10.00% | -9.00% | 2.00% | 2.00% | 0.00% | 0.00% | 4.00% | -4.00% | -1.00% | -2.00% | 6.00% | -3.00% | 8.00% | 9.00% | 15.00% | 0.00% | 3.00% | 2.00% | 8.00% | 8.00% | 4.00% | 5.00% | -12.00% | 7.00% | -2.00% | 2.00% | 3.00% | 7.00% | 4.00% | 4.00% | -7.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 2 | -4 | -1 | 1 | -1 | -1 | 0 | -2 | -1 | -2 | 1 | -1 | 1 | 1 | 2 | -1 | 0 | 1 | 0 | 1 | 0 | 0 | -2 | 0 | -1 | 1 | -1 | 0 | 0 | 0 | -2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 2 | -4 | -1 | 1 | -1 | -1 | 0 | -2 | -1 | -2 | 1 | -1 | 1 | 1 | 2 | -1 | 0 | 1 | 0 | 1 | 0 | 0 | -2 | 0 | -1 | 2 | -1 | 0 | 0 | 0 | -2 |
| Earnings Per Share (₹) | 0.38 | 3.17 | -7.03 | -2.02 | 0.08 | -2.41 | -1.81 | -0.50 | -4.03 | -2.32 | -3.80 | 1.04 | -2.48 | 1.68 | 1.29 | 3.84 | -2.05 | -0.67 | 2.23 | 0.27 | 1.63 | -0.50 | -0.66 | -3.68 | 0.16 | -2.59 | 2.96 | -1.55 | 0.01 | -0.56 | -1.16 | -4.46 |
GKB Balance Sheet — Assets, Liabilities & Shareholders' Equity
GKB total assets ₹132 Cr, total equity ₹53 Cr, total liabilities ₹ Cr (2026) — ROE 1.9%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 132 | 125 | 115 | 112 | 110 | 107 | 102 | 93 | 83 | 82 | 69 | 75 |
| Current Assets | 108 | 99 | 88 | 84 | 76 | 74 | 73 | 64 | 64 | 63 | 51 | 46 |
| Fixed Assets | 19 | 17 | 18 | 19 | 23 | 24 | 26 | 26 | 18 | 18 | 13 | 12 |
| Capital Work in Progress | 4 | 4 | 4 | 4 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
| Investments | 55 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 4 | 6 | 0 |
| Other Assets | 0 | 102 | 91 | 87 | 82 | 80 | 75 | 67 | 64 | 60 | 50 | 63 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 6 | 6 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 53 | 56 | 64 | 67 | 67 | 66 | 59 | 55 | 45 | 47 | 45 | 40 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 48 | 47 | 55 | 58 | 58 | 58 | 54 | 47 | 41 | 43 | 41 | 36 |
GKB Cash Flow Statement — Operating, Investing & Financing
GKB Ophthalmics operating cash flow ₹-3 Cr, investing ₹3 Cr, financing ₹1 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -3 | 4 | -3 | 5 | 7 | 3 | 4 | -3 | -3 | -11 | 7 |
| Investing Activities | 3 | -2 | 1 | -4 | -17 | -4 | -10 | 1 | 4 | 15 | -1 |
| Financing Activities | 1 | -2 | -2 | -2 | 3 | 4 | 13 | 1 | -1 | -3 | -6 |
| Net Cash Flow | 0 | 1 | -4 | 0 | -7 | 4 | 7 | 0 | -1 | 0 | 1 |